| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |